Company: BIAF
Filing Date: 2025-05-02
Form Type: S-1
Source: 0001641172-25-008170
Chunk: 157

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-02
Form: S-1
Chunk 157
---
/2024 |     | Vests                                                                        
 in equal annual installments over the 3 years following the date of grant    |
| S.         
 Girgenti   |     | 8/9/2023  |     | Vests                                                                        
 on third anniversary of the grant date, August 9, 2026                       |
|            |     | 1/31/2024 |     | Vests                                                                        
 in equal monthly installments over the 12 months following the date of grant |
|            |     | 2/16/2024 |     | Vests                                                                        
 on third anniversary of the grant date, February 16, 2027                    |
|            |     | 7/1/2024  |     | Vests                                                                        
 in equal monthly installments over the 12 months following the date of grant |

| (2) | Calculated                                                                                                                    
 by multiplying the closing price per share of the Company’s common stock on December 31, 2024, $0.91 by the number of shares. |

| 73 |

Director Compensation

2024 Director Compensation Program

Our 2024 director compensation program included the following components:

| ● | an                                                                                  
 annual cash retainer of $25,000 (payable in four quarterly installments of $6,250); |

| ● | an                                                                                                                           
 additional annual cash retainer of $10,000 for the Chairman of the Board (payable in four quarterly installments of $2,500); |

| ● | an                                                                                                                          
 additional annual cash retainer of $5,000 for the Audit Committee Chair (payable in four quarterly installments of $1,250); |

| ● | an                                                                                                                               
 additional annual cash retainer of $2,500 for the Compensation Committee Chair (payable in four quarterly installments of $625); |

| ● | an                                                                                                                                  
 additional annual cash retainer of $2,500 for the Nominating and Governance Committee Chair (payable in four quarterly installments 
 of $625); and                                                                                                                       |

| ● | an                                                                                                                                  
 annual equity grant of restricted stock with a grant date value of approximately $75,000 that vests pro rata on a monthly basis for 
 12 months.                                                                                                                          |

The table below summarizes the compensation paid to the Company’s non-NEO directors who served on the Board during the fiscal year ended December 31, 2024.

| Name            |     | Fees             
 Earned